Background-Signaling from phosphoinositide 3-kinase ␥ (PI3K␥) is crucial for leukocyte recruitment and inflammation but also contributes to cardiac maladaptive remodeling. To better understand the translational potential of these findings, this study investigates the role of PI3K␥ activity in pressure overload-induced heart failure, addressing the distinct contributions of bone marrow-derived and cardiac cells. Methods and Results-After transverse aortic constriction, mice knock-in for a catalytically inactive PI3K␥ (PI3K␥ KD) showed reduced fibrosis and normalized cardiac function up to 16 weeks. Accordingly, treatment with a selective PI3K␥ inhibitor prevented transverse aortic constriction-induced fibrosis. To define the cell types involved in this protection, bone marrow chimeras, lacking kinase activity in the immune system or the heart, were studied after transverse aortic constriction. Bone marrow-derived cells from PI3K␥ KD mice were not recruited to wild-type hearts, thus preventing fibrosis and preserving diastolic function. After prolonged pressure overload, chimeras with PI3K␥ KD bone marrow-derived cells showed slower development of left ventricular dilation and higher fractional shortening than controls. Conversely, in the presence of a wild-type immune system, KD hearts displayed bone marrow-derived cell infiltration and fibrosis at early stages but reduced left ventricular dilation and preserved contractile function at later time points. Conclusions-Together, these data demonstrate that, in response to transverse aortic constriction, PI3K␥ contributes to maladaptive remodeling at multiple levels by modulating both cardiac and immune cell functions. (Circulation. 2011; 123:391-399.)
C hallenging the heart by mechanical or neurohumoral stimulation triggers complex biological responses that culminate in tissue remodeling. This adaptive process is aimed mainly at enhancing cardiac performance and is characterized by modifications in both the cellular and extracellular compartments. 1
Clinical Perspective on p 399
Physiological stimuli such as physical training increase cardiomyocyte size, leading to adaptive left ventricular (LV) concentric hypertrophy without altering function. On the contrary, pathological conditions such as myocardial infarction, hypertension, and heart valve dysfunction induce LV remodeling, which initially starts as compensatory hypertrophy but evolves, acquiring maladaptive features and ultimately triggering transition to heart failure. 2 During the progression to heart failure, stressed cardiomyocytes progressively display contractile dysfunction and cell death. 3 This process is associated with inflammation, fibrosis, and reduced capillary density. 4 Further understanding of the molecular mechanism leading to pathological cardiac remodeling is critical for the development of novel therapies aimed at ameliorating cardiac dysfunction.
An emerging suitable candidate for therapeutic intervention could be phosphoinositide 3-kinase ␥ (PI3K␥), a lipid and protein kinase expressed in both cardiac and bone marrow (BM)-derived cells. Indeed, PI3K␥ regulates leukocyte migration by triggering the accumulation of phosphatidyl (3, 4, 5) -triphosphate at the leading edge. 5, 6 Conversely, in cardiomyocytes, PI3K␥ negatively controls cAMP levels as a scaffold protein 7, 8 and plays a pivotal role during the internalization of activated ␤-adrenergic receptors via its kinase activity. 9 In agreement with a role for PI3K␥ in regulating cardiac function, mice homozygous for a mutant allele of the PI3K␥ gene, causing the loss of catalytic activity (PI3K␥ KD), display reduced cardiac fibrosis after 1 week of TAC-induced pressure overload. 8 Although this was accompanied by decreased infiltration of inflammatory cells, expression of PI3K␥ KD in both BM-derived cells and cardiomyocytes has disallowed the definition of the precise roles of these cells in the development of cardiac remodeling.
To better define the translational potential of PI3K␥ inhibition in preclinical models and to clarify the cell types involved, we analyzed PI3K␥ KD mice and BM chimeras with BM-derived cells and hearts of different genotypes in long-term pressure overload. We show that PI3K␥ KD mice were protected from maladaptive remodeling and cardiac dysfunction up to 16 weeks after aortic banding. Moreover, using PI3K␥ KD BM chimeras, we demonstrate that inhibition of PI3K␥ in both BM-derived and cardiac cells is required to protect from heart dysfunction, indicating that PI3K␥ inhibition, through its combined effects in different cell types, represents a potential tool in the prevention of heart failure.
Methods

Mice and Surgical Procedures
Knock-in mice with catalytically inactive PI3K␥ (KD) were generated as previously described. 8 Mutant mice were crossed with C57Bl/6 mice for 15 generations to inbreed the genetic background, and C57Bl/6 mice were used as wild-type (WT) controls.
Mechanical stress was imposed on the LV by transverse aortic constriction (TAC) as previously described. 8 Suitable pressure gradients (60 to 90 mm Hg), an index of biomechanical stress, were determined by echo Doppler. Diastolic function was evaluated with a micromanometer catheter (Millar 1.4F, SPR 671, Millar Instruments, Inc, Houston, TX).
Pharmacological inhibition of PI3K␥ was performed by intraperitoneal injections 10 of AS605240 at 50 mg ⅐ kg Ϫ1 ⅐ /d Ϫ1 (Merk Serono, Geneva, Switzerland) for 2 weeks immediately after aortic banding or for 2 weeks starting from the second week after TAC.
BM Transplantation
Medullar aplasia of 8-to 12-week-old mice was obtained by lethal total body irradiation with a dose of 10 Gy. Next, Ϸ20ϫ10 6 BM-derived cells obtained from femurs and tibias of donor mice were injected into the tail vein of irradiated mice. Transplanted mice were subjected to experiments after a minimum of 3 weeks of recovery. The transplantation rate was assessed by real-time polymerase chain reaction on blood genomic DNA amplifying the Pik3cg-WT gene. The Pik3cb gene represented the internal control. Animals with Ͻ80% of donor origin-circulating cells were excluded from the study (Figure I in the online-only Data Supplement).
Histological Analysis and Immunohistochemistry
Histology and immunohistochemistry were performed on paraffin and cryosections following standard protocols. For details, see the online-only Data Supplement.
Analysis of Gene Expression
Relative mRNA analysis of Col11 (collagen-1), Fn1 (fibronectin), Tgfb1 (transforming growth factor [TGF]-␤1), Il6 (interleukin [IL]-6), Ccl2 (monocyte chemoattractant protein-1), Ccl3 (macrophage inflammatory protein-1␣), Il1b (IL1␤), Mmp2 (matrix metalloproteinase [MMP]2), Mmp9 (MMP9), and Mmp14 (MMP14) was performed by real-time polymerase chain reaction (ABI Prism 7300 Real-Time PCR System, Applied Biosystems, Foster City, CA) with Taqman assays using the Universal Probe Library System (Roche Applied Sciences, Indianapolis, IN). We used 18s as the endogenous control. Primers sequences are listed in Table I in the online-only Data Supplement.
Echocardiography
Two-dimensional guided M-mode echocardiography was performed in conscious WT and KD mice with a GE System 5 echocardiograph. Chimeric mice anesthetized with avertin (tribromo-ethanol, Sigma, Milan, Italy) were analyzed with a Vevo770 High Resolution Imaging System (Visual Sonics Inc, Toronto, Ontario, Canada). Echocardiographic parameters were measured in the long-axis M mode. Cardiac function was assessed when heart rate was Ϸ500 to 600 bpm.
Statistical Analysis
Echocardiographic analyses were tested with repeated measures 2-way ANOVA and Bonferroni posthoc test. Statistical significance of nonrepeated measures was calculated with the Kruskal-Wallis test with Dunn posthoc tests. Correlation of differences in end-diastolic pressure between TAC and sham mice (⌬EDP) in terms of pressure gradient (⌬P) was calculated with the nonparametric Spearman method. Statistical analyses were performed with GraphPad software PRISM5 (GraphPad Software Inc, La Jolla, CA).
Results
KD Mice Are Protected From Pressure Overload-Induced Maladaptive Remodeling
Previous studies indicate that mice expressing a kinase-dead PI3K␥ (KD mice) are protected from the short-term effects of pressure overload. 8 To establish whether the expression of PI3K␥ KD protected against long-term TAC-induced LV dilation and cardiac dysfunction, mice were subjected to pressure overload (WT, ⌬Pϭ70Ϯ1.9 mm Hg; KD, ⌬Pϭ71Ϯ5.1 mm Hg; Pϭ0.95) for 16 weeks and serially analyzed by echocardiography ( Figure 1A ). After 4 weeks of TAC, WT and KD mice exhibited a significant increase in relative wall thickness (RWT; Figure 1B ) compared with baseline levels, indicating the onset of concentric hypertrophy. LV end-diastolic diameter (LVEDD) of WT mice after 16 weeks of TAC was higher than baseline, whereas LV diameter in KD mice did not increase after 16 weeks of TAC ( Figure 1C ). Additionally, KD mice had preserved systolic contractile function after 16 weeks of pressure overload as measured by the percentage of fractional shortening (FS%; Figure 1D ). Altogether, these data show that KD mice do not display signs of maladaptive remodeling caused by long-term pressure overload, significantly preserving cardiac performance up to 16 weeks after TAC.
Histological analysis of hearts at 16 weeks after TAC showed a similar hypertrophic response in both WT and KD cardiomyocytes, with a 3-fold increase over baseline in the cross-sectional area (WT sham, 108.38Ϯ2.36 m 2 ; WT TAC, 327.96Ϯ6.17 m 2 , PϽ0.001; KD sham, 112.10Ϯ2.20 m 2 ; KD TAC, 310.22Ϯ4.35 m 2 , PϽ0.001). On the other hand, apoptosis was significantly increased only in WT hearts (WT sham, 0.13Ϯ0.06 cells per 1 mm 2 ; WT TAC, 0.57Ϯ0.06 cells per 1 mm 2 , PϽ0.05; KD sham, 0.11Ϯ0.02 cells per 1 mm 2 ; KD TAC, 0.34Ϯ0.05 cells per 1 mm 2 , Pϭ0.30). Furthermore, fibrosis increased in WT hearts but remained at basal levels in aortic banded KD mice (Figure 2A and 2B). Therefore, both echocardiographic and histological analyses indicate that, in long-term TAC, PI3K␥ KD expression protects hearts against maladaptive remodeling.
Pharmacological Inhibition of PI3K␥ Prevents Myocardial Fibrosis
The role of PI3K␥ kinase activity during pressure overload was further investigated through pharmacological inhibition of the enzyme using the selective PI3K␥ inhibitor AS605240. 10 Banded WT mice treated with AS605240 or vehicle for 2 weeks after aortic banding displayed a comparable hypertrophic re-sponse of cardiomyocytes, as indicated by the cross-sectional area (sham, 79.50Ϯ1.76 m 2 ; vehicle TAC, 204.95Ϯ3.52 m 2 ; AS605240 TAC, 200.79Ϯ3.05 m 2 ; vehicle TAC versus sham, PϽ0.001; AS605240 TAC versus sham, PϽ0.001; vehicle TAC versus AS605240 TAC, Pϭ0.24). Nonetheless, fibrosis was significantly lower in AS605240-receiving mice than in vehicletreated controls (vehicle-treated WT versus sham, PϽ0.01; versus AS605240-treated WT, PϽ0.05; Figure 2C and 2D). Conversely, when the inhibitor was administered starting from the second week after banding, fibrosis was not affected (data not shown), thus indicating that the PI3K␥-dependent process driving fibrotic remodeling was restricted to the first week after TAC.
Generation of BM Chimeric Mice
To assess whether PI3K␥-dependent fibrosis was linked to the role of this enzyme in the immune system, the specific contributions of PI3K␥ in either BM-derived cells or cardiac cells were studied through the use of chimeric mice generated by BM transplantation. WT and KD mice were subjected to total body irradiation and BM transplantation to obtain 3 groups of chimeras: WT mice with KD immune system (KD3 WT), KD mice with WT immune system (WT3 KD), and WT mice with WT immune system (WT3 WT) as controls.
Cardiac Recruitment of BM-Derived Cells Depends on a Cell Autonomous PI3K␥ Function
Chimeric mice were subjected to TAC, and pressure gradients were equal in the 3 groups (WT3 WT, ⌬Pϭ72.7Ϯ3.2 mm Hg; KD3 WT, 73.4Ϯ2.9 mm Hg; WT3 KD, 74.9Ϯ3.4 mm Hg; Pϭ0.90). After 3 days of pressure overload, at the peak of the TAC-induced inflammatory response, 11 the number of CD18 ϩ leukocytes infiltrating the myocardium increased significantly in WT3 WT and WT3 KD hearts, whereas no increase was detectable in KD3 WT mice ( Figure 3A and 3B). This difference was paralleled by a significantly weaker oxidative stress (measured as the amount of nitrosylated proteins) in KD3 WT than in the other groups ( Figure II Inflammatory cells accumulating in the myocardium might represent an additional source of proinflammatory mediators. 4 At 2 weeks after TAC, mRNA for macrophage inflammatory protein-1␣/CCL3 was upregulated in WT3 WT and WT3 KD banded hearts by 2-and 2.5-fold, respectively, but remained at a basal level in KD3 WT mice ( Figure 4A) . Similarly, the increase in IL6 mRNA synthesis was significantly lower ( Figure 4A ) in KD3 WT hearts, where infiltrating BM-derived cells were absent. Conversely, upregulation of the stress-induced cytokine IL1␤ was similar in all TAC-treated groups ( Figure 4A) , indicating that the regulation of specific cytokines is, at least in part, independent of the local presence of inflammatory cells.
Inflammatory signals may influence vascularization and thereby oxygen supply of inflamed tissue; thus, LV capillary density was analyzed. Basal values appeared equal, and after 2 weeks of TAC, their increase was similar in all 3 groups ( Figure 4B ), indicating that, in this context, recruitment of BM-derived cells did not affect myocardial capillary density. 
Leukocyte Recruitment Triggers Cardiac Fibrosis
To evaluate the effects of BM-derived cell recruitment on myocardial fibrosis, Picrosirius Red staining of collagen was performed. Whereas after 2 weeks of TAC treatment, the area of fibrosis in WT3 WT and WT3 KD hearts increased 4and 3-fold, respectively, the levels of fibrosis in KD3 WT mice were not significantly higher than baseline ( Figure 5A and 5B).
In agreement with histology, collagen I transcription was 2.5-fold upregulated in WT3 WT and WT3 KD samples ( Figure 6A ). Similarly, fibronectin was 2-and 2.5-fold upregulated in the WT3 WT and WT3 KD groups, respectively ( Figure 6A ). Conversely, at 2 weeks after TAC, there was no change in collagen I and fibronectin in KD3 WT mice ( Figure 6A ). In agreement with extracellular matrix (ECM) remodeling, MMP2 and MMP14 were upregulated 2-fold only in WT3 WT and WT3 KD LVs (Figure 6B ). MMP2 and MMP14 expression returned to basal levels at In the heart, increased expression of ECM components is evoked mainly by TGF␤, 12 a cytokine produced by fibroblasts and infiltrating macrophages. 13 After 2 weeks of TAC, the expression of TGF␤ mRNA was 2-fold higher in WT3 WT and WT3 KD LVs than sham controls (PϽ0.05 both). Conversely, mRNA expression of this cytokine remained at basal levels in KD3 WT mice ( Figure 6C ), thus indicating that the inhibition of leukocyte PI3K␥ is the main factor contributing to the protection against cardiac fibrosis in PI3K␥ KD mice.
A significant direct relationship between ⌬EDP and ⌬P was found in WT3 WT animals (Spearman rϭ0.862, Pϭ0.01), thus suggesting that fibrosis, making hypertrophic LV walls stiffer, impaired diastolic function proportionally to loading conditions ( Figure 6D, top) . Accordingly, WT3 KD mice, which developed levels of fibrosis similar to those of WT3 WT mice, showed a trend toward a correlation among ⌬EDP and ⌬P with a high r value (rϭ0.900, Pϭ0.08). In contrast, the absence of fibrosis in KD3 WT hearts, subjected to similar loading conditions and developing a hypertrophy comparable to that of WT3 WT mice, prevented the establishment of a direct relation between ⌬EDP and ⌬P (rϭ0.119, Pϭ0.793; Figure 6D , top). Similar results were detected in PI3K␥ KD mice (WT: rϭ1.000, Pϭ0.01; KD: rϭ0.485, Pϭ0.35; Figure 6D , bottom).
Blockade of Either Cardiomyocyte or Leukocyte PI3K␥ Improves Long-Term Heart Response to Pressure Overload
In pressure overload, diastolic dysfunction precedes deterioration of systolic performance. 14, 15 Chimeric mice subjected to TAC were thus studied by echocardiography for up to 16 weeks (WT3 WT, ⌬Pϭ71.4Ϯ4.4 mm Hg; KD3 WT, 74.0Ϯ3.9 mm Hg; WT3 KD, 75.7Ϯ4.5 mm Hg; Pϭ0.88; Figure V in the online-only Data Supplement).
After 4 weeks of aortic banding, RWT significantly increased in all 3 groups (4-week TAC versus basal, PϽ0.001), indicating a similar onset of concentric hypertrophy ( Figure  7A, left) . At later time points, WT3 WT LV displayed a progressive transition from concentric to dilated hypertrophy that was blocked in WT3 KD LV and delayed in KD3 WT LV ( Figure 7A) .
In parallel, LV chamber diameter (LVEDD) increased progressively in WT3 WT mice and became significantly different from baseline by 12 weeks after TAC ( Figure 7A , center; 12-week TAC versus basal, PϽ0.01). In contrast, at this stage, LVEDD of KD3 WT mice remained unaltered and significantly smaller than that of WT3 WT controls (Figure 7A , center). After 16 weeks of TAC, LV chambers were dilated in KD3 WT mice also ( Figure 7A, center) . Conversely, at this same time point, WT3 KD hearts showed significantly limited late-stage upregulation of MMP9 16 (Figure 7B ) and preserved normal LVEDD ( Figure 7A , center; 16-week TAC versus basal, Pϭ1). Therefore, analysis of RWT, LVEDD, and MMP9 expression indicated that cardiac maladaptive remodeling was blocked by PI3K␥ inhibition in the heart and slowed by PI3K␥ inhibition in BM-derived cells.
Despite similar LV chamber dilation in WT3 WT and KD3 WT animals at 16 weeks after TAC, KD3 WT mice were characterized by reduced myocardial fibrosis ( Figure  7C ) and cardiomyocyte apoptosis ( Figure VI in the onlineonly Data Supplement). In parallel, at this stage, WT3 WT animals displayed a smaller number of capillaries in the myocardium compared with WT3 KD animals, indicating a better oxygen supply in the myocardium of the latter group ( Figure 7D) . Consistently, at 16 weeks after TAC, LV systolic function (FS%) was retained in both KD3 WT and WT3 KD mice, whereas starting from the 12th week, FS% was significantly impaired in WT3 WT controls ( Figure 7A , right). Thus, although PI3K␥ inhibition in cardiac cells was able to prevent cardiac dilation without counteracting fibrosis, specific blockade of PI3K␥ in BM-derived cells preserved systolic function but only delayed LV dilation. These data indicate that the complete protection observed in PI3K␥ KD mice requires concomitant PI3K␥ inhibition in both cardiac and BM-derived cell populations.
Discussion
In this study, we provide evidence that the lack of PI3K␥ activity protects against heart failure in a mouse model of pressure overload generated by TAC. Indeed, in mice ex- Figure 6 . Expression of matrix genes in LVs of BM chimeras after 2-week TAC and diastolic function. A through C, Relative quantification of mRNA levels of genes coding for collagen-1 (WT3 WT: sham, nϭ6; TAC, nϭ8; KD3 WT: sham, nϭ7; TAC, nϭ12; WT3 KD: sham, nϭ7; TAC, nϭ10), fibronectin (all sham groups, nϭ7; TAC: WT3 WT and WT3 KD, nϭ9; KD3 WT, nϭ14) (A), MMP2 (all sham groups, nϭ5; TAC: WT3 WT, nϭ8; KD3 WT, nϭ12; WT3 KD, nϭ11), MMP14 (all sham groups, nϭ5; TAC: WT3 WT, nϭ10; KD3 WT, nϭ13; WT3 KD, nϭ11) (B), and TGF␤ (WT3 WT and WT3 KD: sham, nϭ6; TAC, nϭ8; KD3 WT: sham, nϭ5; TAC, nϭ13) (C). Significance vs KD3 WT: *PϽ0.05, **PϽ0.01; significance vs baseline: #PϽ0.05, ##PϽ0.01, ###PϽ0.001. D, Graphs representing EDP as the difference between TAC and sham mice EDP (⌬EDP) in relation to ⌬P in BM chimeras (top; TAC WT3 WT, nϭ8; TAC KD3 WT, nϭ8; TAC WT3 KD, nϭ5) and PI3K␥ KD mice (bottom; TAC PI3K␥ WT, nϭ5; TAC PI3K␥ KD, nϭ6) 2 weeks after TAC determined by Millar catheterization. For each group, best-fit linear regression lines are shown.
pressing a catalytically inactive PI3K␥, we did not detect signs of myocardial fibrotic deposition or systolic dysfunction in a 16-week follow-up of aortic banding, whereas adaptive hypertrophy developed regularly. Taken together, these findings pinpoint PI3K␥ as a key player, as well as an intriguing drug target, in the natural history of heart failure. However, PI3K␥ is normally expressed in both BM-derived cells and cardiac cells. 8 In cardiomyocytes, PI3K␥ catalytic activity is critically involved in signaling events controlling ventricular contractility and remodeling in response to mechanical stress. For instance, it regulates ␤-adrenergic receptor signaling by modulating receptor internalization, 9, [17] [18] [19] a molecular hallmark of heart failure. 18 Within the immune system, PI3K␥ has a prominent role in driving leukocyte chemotaxis and recruitment in sites of inflammation. 5, 6, 8, 20 Therefore, it is possible that both cardiac and leukocyte PI3K␥ may account for the observed cardioprotection of PI3K␥ inactivation, in which case the use of KD or knockout mice alone is insufficient to ascertain the relative contribution of each component in this process. To address this issue, we examined cardiac remodeling in chimeric mice expressing a KD PI3K␥ solely in BM-derived or in non-BM-derived cells through the use of BM transplantation.
The analysis of chimeric mice expressing a kinase-inactive PI3K␥ only in BM-derived cells (KD3 WT mice) confirmed that leukocyte PI3K␥ critically controls the number of white blood cells infiltrating the myocardium early after TAC. Remarkably, KD3 WT mice also presented a clear-cut reduction in interstitial fibrotic deposition and preserved diastolic function. Differences in myocardial fibrosis between KD3 WT and WT3 WT mice persisted at late time points (16 weeks), albeit slightly reduced compared with earlier phases (2 weeks). Conversely, in WT3 KD mice, both myocardial BM-derived cell infiltration and subsequent fibrosis were comparable to that in WT3 WT controls. Although it is still possible that PI3K␥ is involved in the cardiac recruitment of fibroblast progenitors, our findings suggest that leukocyte PI3K␥ links the recruitment of BM-derived cells to fibrotic deposition, especially in its earlier development. Consistently, we found that the profibrotic factor TGF␤ and its downstream effectors collagen I and fibronectin were upregulated in hearts in which infiltration of leukocytes was elevated but remained similar to sham in WT mice with KD immune system. In line with this view, our results suggest that the TGF␤ produced by infiltrating macrophages 13 triggers ECM deposition through the paracrine secretion of this profibrotic factor. Indeed, the reduction in macrophage recruitment blocked fibrosis early after TAC. Although leukocyte infiltration resolves itself by 1 month after banding, 21 it is possible that the effects on ECM deposition and subsequent remodeling may continue at later time points. Changes in ECM structure can be further driven by TGF␤, which instructs fibroblasts to produce metalloproteinases like MMP2 and MMP14. 13 In agreement, upregulation early after TAC of MMP2 and MMP14 appeared depressed in the absence of BM-derived cell recruitment, thus likely leading to the later-stage reduction in dilation and contractile dysfunction. Although in our model leukocyte PI3K␥ affected primarily ECM remodeling and diastolic dysfunction, myocardial PI3K␥ was found to be necessary for the development of systolic failure after TAC. The fact that BM-derived cell infiltration, TGF␤ upregulation, and interstitial fibrosis in WT3 KD mice were equal to those in controls indicates that myocardial PI3K␥ does not significantly affect the early inflammatory events triggered by pressure overload. Moreover, WT3 KD hearts showed a trend toward diastolic dysfunction that was very similar to that displayed by WT3 WT mice. However, despite the occurrence of BMderived cell infiltration, cytokine release, and fibrosis, WT3 KD mice were protected from LV dilation and presented normal FS throughout the 16-week follow-up to TAC, similar to PI3K␥ KD mice. A mechanism independent of BMderived cells ameliorating cardiac outcome after pressure overload might reside in the role played by PI3K␥ in the cardiovascular effects of the renin-angiotensin system. 22 Another plausible explanation linking the lack of PI3K␥ activity in cardiomyocytes and the reduced maladaptive response to pressure overload is provided by studies on ␤-adrenergic receptor internalization. 23 Indeed, because PI3K␥ activity is involved in the internalization of activated ␤-adrenergic receptors, banded hearts overexpressing an inactive PI3K␥ mutant show improved response to TAC as a result of sustained ␤-adrenergic signaling in cardiomyocytes. 9, 19, 24 Moreover, the absence of LV dilation in WT3 KD mice could be related to the observed lack of MMP9 induction, 25 a finding in line with previous reports implying cardiac PI3K␥ in its upregulation. 16 With respect to the development of systolic failure, an important observation is that KD3 WT mice developed eccentric hypertrophy later than WT3 WT controls because LVEDD was unchanged up to 12 weeks after TAC. However, in these mice, eccentric hypertrophy developed by 16 weeks, although at this time FS was preserved. One possible explanation for this finding is that the lack of initial myocardial inflammation may delay the natural history of systolic failure. In support of this view, KD3 WT mice were protected from the initial inflammation-evoked oxidative stress and subsequent tissue damage.
Conclusions
Both leukocyte and myocardial PI3K␥ are required for TAC-induced development of heart failure. On the one hand, leukocyte PI3K␥ conditions inflammatory cell recruitment and the consequent fibrosis. However, on the other hand, PI3K␥ activity in cardiomyocytes is not critically involved in early fibrotic remodeling but has an important effect on the loss of systolic function and LV dilation. Importantly, the molecular mechanisms appear open to pharmacological modulation; in fact, the pathophysiological role of PI3K␥ has been shown in a number of inflammatory diseases such as rheumatoid arthritis, 10 glomerulonephritis, 26 and atherosclerosis, 27 and this enzyme currently represents a promising drug target for novel antiinflammatory treatments. 28, 29 Our findings consistently demonstrate that administration of a PI3K␥ inhibitor prevented pressure overload-induced fibrotic remodeling. Although the same treatment was not able to reverse established fibrosis, our results show that genetic inhibition of PI3K␥ in cardiac tissue improves contractility independently of ECM alteration. Our findings represent a proof of concept that pharmacological targeting of cardiac PI3K␥ with a suitable inhibitor represents a feasible strategy for the treatment of heart failure through combined actions on both inflammatory and cardiac cells.
